Edoardo Cignoli : Onyx CEO Could Make More Than $60 Million From Amgen Deal

Onyx Pharmaceuticals Chief Executive N. Anthony Coles could leave the drug maker with more than $60 million if he departs the company once it is taken over by Amgen.



via WSJ.com: US Business http://online.wsj.com/article/SB10001424127887324886704579053490378011908.html?mod=pls_whats_news_us_business_f